The life sciences industry is no stranger to mergers and acquisitions (M&As), helping to expand product portfolios, access new markets and pursue new innovations, amongst a myriad of other reasons. In this article, we will look at the current state of M&A activity based on data from the Biotechgate database, with insights on where the … Continue reading The Current State of M&A Activity in the Life Sciences Industry
Category: M&A Transactions
Life Sciences M&A Report: Half-Year 2023
In the first half of 2023, the slowdown in terms of global life sciences M&A deal-making experienced in the second half of 2022 has continued to show its effects. Anticipated as a year of recovery, 2023 was expected to leverage M&A as a means to adapt to rapidly changing market conditions. However, while it remains … Continue reading Life Sciences M&A Report: Half-Year 2023
Introducing M&A deals to Biotechgate
Biotechgate is continuously working on enhancements and new tools to boost the experience for our users. Currently, Biotechgate is developing a new release, which is planned for early 2024: Among the various new features that subscribers can look forward to, one in particular worth highlighting revolves around M&A deals and is unique on the market … Continue reading Introducing M&A deals to Biotechgate
Life Sciences M&A Report
In line with the broader negative trend in overall M&A investment worldwide, the global M&A activity in the life sciences industry experienced a slowdown in 2022: M&A activity declined significantly in both the number and value of deals compared to the previous year. However, there is hope that 2023 will be a more active year … Continue reading Life Sciences M&A Report
The 8 Largest Biopharma M&A Deals of 2022 (Jan-Sep)
Despite 2022 being a relatively quiet year for M&A activity within the biopharma space, especially when compared to 2021, a number of prominent deals have taken place. Find out the 8 largest M&A deals of the year so far in order of the total amount. 8. Zogenix Acquired by: UCB Amount: USD 1.9bn After Zogenix’s … Continue reading The 8 Largest Biopharma M&A Deals of 2022 (Jan-Sep)